Diet Pills and the FDA
Diet Pills and the FDA
Each year, millions of Americans resolve to lose weight—it is one of the most common New Year’s resolutions. Many people start off with great intentions, but within months, weeks, or even days, most of them give up and return to their usual habits. If they work to lose [...]
Experimental Obesity Drug APD356 Reported Effective in Small, Short Trial
A year ago at this time, millions of overweight and obese An experimental drug for the treatment of obesity, APD356, reportedly produced encouraging results in a relatively small four week clinical trial, according to a statement released by Arena Pharmaceuticals, Inc Acomplia (rimonabant) .
Arena said [...]
New Acomplia News Will Be Presented on March 8th
After a four-month dry spell during which there has been little news about development of the highly publicized obesity drug Acomplia (rimonabant) , researchers are scheduled to present new data from the RIO–Europe clinical trial at a scientific meeting in Orlando on Tuesday, March 8th.
The presentation of [...]
2d Generic Version of Diet Pill Rimonabant (Acomplia / Zimulti) Launched in India
ond Acomplia (rimonabant) Indian pharmaceutical company, Torrent Pharmaceuticals Ltd., has announced that it also is selling a generic version of the new Sanofi-Aventis diet drug Acomplia (rimonabant) under the name Rimoslim.
The news, which attracted little attention in the West, occurred almost simultaneously with last week’s announcement by Zydus [...]
Regulators Will Be Wary in Weighing Up Acomplia
The Guardian, in the following story published on January 10, 2005, says that while Sanofi is confident it has a winner in the new anti–obesity drug Acomplia, it can expect close scrutiny during the approval process of the side effects.
Want to lose weight, stop smoking and cut [...]
Diet drug r Acomplia (rimonabant) was approved for sale on April 3rd by Switzerland for treatment of obese or overweight patients with at least one type of associated cardiovascular risk.
The approval by Switzerland, which is not a member of the European Union, is similar to the EU [...]
New Patients Sought for Study of Acomplia Role in Curbing Alcohol Consumption
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is continuing to seeking volunteers for a Phase II clinical trial exploring the potential of the promising obesity drug Acomplia (rimonabant) (rimonabant) in curbing alcohol consumption.
A spokesperson for NIAAA said the trial of “Rimonabant to Reduce Alcohol Consumption,” [...]
Diet Drug Acomplia (Rimonabant, Zimulti) Reaches End of Road
The end of the road for diet drug Acomplia (Rimonabant, Zimulti) was effectively reached on Nov. 5th when French drugmaker Sanofi-Aventis announced it was halting all further research on what it once expected to be the next blockbuster diet pill.
“ It’s over,” Sanofi spokesperson Jean Marc [...]
